BMJ
- WISE J
Covid vaccines are not linked to sudden death in healthy younger adults, study
finds.
BMJ. 2026;392:s589.
J Infect Dis
- CHEN WH, Beckett CG, Al-Ibrahim M, Datar R, et al
Safety and Immunogenicity of a Trivalent Salmonella Conjugate Vaccine to S.
Typhi, S. Typhimurium, and S. Enteritidis.
J Infect Dis. 2026 Mar 26:jiag156. doi: 10.1093.
- KACHIKIS A, Frivold C, Pike M, Reed JC, et al
Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in
Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination.
J Infect Dis. 2026 Mar 26:jiag111. doi: 10.1093.
- JIHAD T, Chi XS, He Z, Lee K, et al
Establishment of a Neonatal Natural Transmission Model for CMV Vaccine
Development.
J Infect Dis. 2026 Mar 23:jiag170. doi: 10.1093.
- PERSSON C
Comment on: "Mucosal and Systemic Antibody Responses After Boosting With a
Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine".
J Infect Dis. 2026 Mar 20:jiag180. doi: 10.1093.
J Virol
- WANG J, Chang J, Jiang Z, Deng H, et al
An oral rotavirus-vectored vaccine confers protection against Clostridium
perfringens and rotavirus.
J Virol. 2026 Mar 26:e0017826. doi: 10.1128/jvi.00178.
MMWR Morb Mortal Wkly Rep
- HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
Vaccination Coverage by Age 24 Months Among Children Born in 2021 and 2022 -
National Immunization Survey-Child, United States, 2022-2024.
MMWR Morb Mortal Wkly Rep. 2026;75:146-155.
N Engl J Med
- OPEL DJ, O'Leary ST
Communicating about Vaccines in a Politically Contentious Climate.
N Engl J Med. 2026;394:1145-1147.
Nat Med
- HAANEN JB, Schumacher TNM, Kagan JC, Fritsch EF, et al
Publisher Correction: Clinical development of cancer vaccines.
Nat Med. 2026 Mar 26. doi: 10.1038/s41591-026-04361.
Pediatr Infect Dis J
- DE BOCK M, Marbaix S, Goovaerts H, Debieve F, et al
Health and Economic Impact of Seasonal Maternal Vaccination With Bivalent
Respiratory Syncytial Virus Prefusion F Vaccine in Belgium.
Pediatr Infect Dis J. 2026 Apr 7. doi: 10.1097/INF.0000000000005226.
PLoS One
- YAN K, Yang G, Yan L, Wu L, et al
Global trends and forecasts of cervical cancer and a real-world safety assessment
of human papillomavirus vaccines in women: A systematic analysis of the Global
Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System
database.
PLoS One. 2026;21:e0345286.
Proc Natl Acad Sci U S A
-
Correction for Te et al., Broad beta-CoV immunity and transmission blockade by a
single-dose live-attenuated vaccine with atypical codon usage.
Proc Natl Acad Sci U S A. 2026;123:e2607878123.
Vaccine
- JAMES E, Christie S, Boye B, Githieya D, et al
How to leverage social media to build confidence in COVID-19 vaccines: findings
and lessons learned from nationwide campaigns in four countries.
Vaccine. 2026;79:128475.
- FRAWLEY JE, Hutchens J, Wiley K, Mahimbo A, et al
Uptake of Commonwealth funded influenza vaccines for Australian children aged
6-months to <5 years during the COVID-19 pandemic.
Vaccine. 2026;79:128514.
- OOI JSG, Hamis NZ, Tan HC, Yee JX, et al
Neutralizing antibody titers do not predict T cell response to live-attenuated
orthoflaviviral vaccination in humans.
Vaccine. 2026;79:128510.
- ZHONG L, Tao L, Zhai Z, Liao L, et al
The stability landscape of mRNA vaccines: challenges and mitigation strategies.
Vaccine. 2026;79:128515.
- VARGAS-ZAMBRANO JC, Arnaud M, Antunes A, Karzazi K, et al
Evaluating pertussis vaccine effectiveness in children under 5 years of age born
in France between 2013 and 2019.
Vaccine. 2026;79:128472.
- SIMON R, Arrogante A, Nogales-Merida S, Diaz-Rosales P, et al
DNA vaccination against viral hemorrhagic septicemia virus (VHSV) affects the
capacity of kidney leukocytes to respond to a posterior viral encounter.
Vaccine. 2026;79:128512.
- MALDEN DE, Ackerson BK, Gee J, Peryer MA, et al
Self-reported reactogenicity of RSV vaccines among older adults: a post-licensure
study within a large integrated healthcare system in Southern California.
Vaccine. 2026;79:128493.
- FANTIN R, Das S, Loria V, Calderon A, et al
Hybrid immunity provides stronger protection against SARS-CoV-2 infection than
vaccination alone: Evidence from a population-based active monitoring study.
Vaccine. 2026;79:128506.
- DENG L, Barton B, Choi P, Clarke L, et al
Clinical, psychological and quality of life outcomes up to 12-months following
thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination
in Australia.
Vaccine. 2026;79:128501.
- HUANG A, Li J, Tang L, Xu X, et al
Cost-effectiveness of hepatitis A vaccination for adults in China: A decision
tree Markov model study.
Vaccine. 2026;79:128509.
- VONDELING GT, Croda J, Jelinek T, Kassianos G, et al
Post-marketing safety evaluation of the live-attenuated chikungunya vaccine
(IXCHIQ).
Vaccine. 2026;79:128491.
- BRIGGS K, Gingerich MC, Gingerich A, Johnson SK, et al
Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and
heterologous challenge in mice and hamsters.
Vaccine. 2026;79:128490.
- QUACH HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, et al
Sex-based differences in mumps immunity after a third dose of
measles-mumps-rubella vaccine.
Vaccine. 2026;79:128480.
- ROSSO A, Riccio M, Renzi E, Patania F, et al
The role of school-based health education in promoting childhood and adolescent
vaccination: A systematic review and Meta-analysis.
Vaccine. 2026;79:128479.
- SILVA LL, Lopes VDS, da Silva DCB, Nemer CRB, et al
Global overview of vaccine trust: Evidence from a scoping review.
Vaccine. 2026;79:128482.
Virology
- MORALES RUIZ S, Wang Z, Miura T, Shida H, et al
Potent protective ability of vaccinia virus LC16 strains lacking the B5R gene.
Virology. 2026;619:110888.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016